Cabaletta Bio - 53 Year Dividend History | CABA
Historical dividend payout and yield for Cabaletta Bio (CABA) since 1971. The current TTM dividend payout for Cabaletta Bio (CABA) as of November 19, 2024 is $0.00. The current dividend yield for Cabaletta Bio as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.124B |
$0.000B |
|
Cabaletta Bio Inc. is a clinical stage biotechnology company. It is focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. The company's product pipeline consists of DSG3-CAART, DSG3/1-CAART, MuSK-CAART and FVIII-CAART which are in clinical stage. Cabaletta Bio Inc. is based in Philadelphia, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
